Lower CVD Risk With Stable DMARD Therapy in Seropositive RA

Patients with seropositive RA on stable DMARD therapy showed a CVD risk comparable with that of the general population, unlike those whose treatment regimen was not stable.

Related Keywords

Oslo , Norway , Norwegian , Eirik Ikdahl , , Norwegian Cardio Rheuma Register , Musculoskeletal Diseases , Diakonhjemmet Hospital , Rheumatoid Arthritis Ra , Heumatoid Arthritis Ra , Acute Stroke , Disease Modifying Antirheumatic Drugs , Sdmards , Simard , Arthritis , Oint Inflammation , Acute Coronary Syndrome Acs , Heart Failure , Hospitals , Cv Risk , Cardiovascular Risk , V Risk Factors , Cardiovascular Risk Factors , Cardiovascular Risk Management , Angina ,